Effects of Canagliflozin on Serum Potassium in People With Diabetes and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
Eur Heart J 2021 Dec 21;42(48)4891-4901, BL Neuen, M Oshima, V Perkovic, R Agarwal, C Arnott, G Bakris, CP Cannon, DM Charytan, R Edwards, JL Górriz, MJ Jardine, A Levin, B Neal, L De Nicola, C Pollock, N Rosenthal, DC Wheeler, KW Mahaffey, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.